User Name Password

back to homepage

Sofame Technologies (SDW.V) - bridge financing discussions

Comment by Objective Capital , Aug 31, 2009
Click for previous reports on this company
Questions? Contact our analyst

A letter of intent has been signed between Sofame and Township Capital, for bridging loans in the sum of between C$1m and C$2m in order to fund current working capital needs and to support its continuing sales and marketing initiatives.

As predicted in our most recent company update, Sofame will need further finance if it is to meet its working capital requirements and sales projections. As an interim measure, this may provide a bridge while evaluating other medium term finance options.

We understand that the cost will be a 10% arrangement fee of the capital sum, with interest set at 15% per annum.

Objective's view:

Although Sofame withdrew its C$5m prospectus filing on 23 July 2009, the company nevertheless continued with its aggressive recruitment in sales and marketing in an attempt to boost revenues.

Because sales have still badly lagged, the effects have been two-fold. First, the company is now saddled with a mis-matched cost structure and secondly, it does not have the necessary working capital to fulfill the bids it was about to win.

It is imperative this funding issue is settled quickly, otherwise Sofame’s manufacturing representatives will not feel confident that the company will be able to deliver on any orders they do win and so will defer. If this happened, this situation could become dire.

Until this issue is resolved, the share price is going to remain weak. Furthermore, as we pointed out in our update note, any hint that sales are going to be materially lower than our core projection will severely punish the core valuation.

The extra capital is now essential for the company, if it is to capitalize on its project pipeline, in whatever form it takes – be it bridging finance, or conceivably, a trade partner taking a majority stake in an enlarged business.

SIGN UP NOW FOR OBJECTIVE'S STOCK RESEARCH - IT'S FREE!

Objective, Independent, Experienced.
Research you can trust!

Yes! Subscribe me for the latest stock research from Objective.
Email address
My Password
My information:
First Name
Family Name
Title:
Job title:
Job function:
Industry:
I am a:
 
To receive occasional printed reports complete your mailing address:
 
Company Name (if any)
Address
 
 
City
Postcode/Zip
Country

Please Read Objective's Terms of Use.


Balkan Resources (Private) - exploring the Perlati copper deposit in Albania
Oct 09, 2009 | Previous Reports

Scancell Holdings (SCLP.PLUS) - differentiated technology and a focused plan offer ingredients for success
Sep 08, 2009 | Previous Reports

Sofame Technologies (SDW.V) - ambitious, but high risk growth strategy
Aug 24, 2009 | Previous Reports

Soho Resources (SOH.V) - substantial upgrade to total resource
Aug 19, 2009 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

e-Therapeutics (ETX.L) - ‘success-predictive’ drug discovery may be the key to new treatment horizons
Nov 18, 2008 | Previous Reports

Great Western Minerals (GWG.V) - pressing ahead with mine-to-market strategy
Nov 07, 2008 | Previous Reports

LiDCO (LID.L) - half year results show early signs of being on track
Oct 30, 2008 | Previous Reports

OCCASIONAL PAPERS

Albania - revisting old frontiers
October, 2008

The rise of independent research (IR Magazine)
March, 2006

Presentation to 2005 AIM Conference
Sept 26, 2005

The Role of Sponsored Research
June 22, 2005

Objective's Corporate Brochure
July 01, 2004

Objective Capital's Contact Information
Partnership, sales and product inquiries: marketing@objectivecapital.co.uk
Media services and conference requests: PR@objectivecapital.co.uk
Subscription and customer service issues: service@objectivecapital.co.uk
Comments or opinions on our analysis: analysis@objectivecapital.co.uk

11-12 Tokenhouse Yard, London EC2R 7AS, United Kingdom
ph +44-(0)870-080 2965 fax +44-(0)870-116 0839

About Us | Contact Us
Latest Analysis | Register Free | Archives
 
Copyright 2004 Objective Capital. All rights reserved.
Terms of Use | Privacy Policy | Disclaimer